LFWD Lifeward Ltd.
HealthcareAs of 2026-05-26
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
1.81
P/S
0.51
EV/EBITDA
-0.37
DCF Value
$-215.91
FCF Yield
-139.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
36.6%
Operating Margin
-120.3%
Net Margin
-123.7%
ROE
-243.1%
ROA
-77.4%
ROIC
-86.3%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $3.9M | $-10.8M | $— |
| Q4 null | $5.1M | $-5.3M | $— |
| FY null | $22.0M | $-19.9M | $— |
| Q3 null | $6.2M | $-3.2M | $— |
Analyst Ratings
View AllConsensus
Buy
Target (Consensus)
$129.00
Target (Median)
$129.00
Target Range
$102.00 - $156.00
Trading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
Medical - Devices
Country
IL
Exchange
—
Beta
0.33
Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Marlborough, MA.